K
Kodiak Sciences D
D
KOD
6.44000
USD
0.25
(4.04%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-2
Market Cap
338,897,105
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Kodiak Sciences
Sector: Healthcare
Industry: Biotechnology
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.